Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
Stock detail
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
OPTIONS CHAIN →
CRDF
Cardiff Oncology, Inc.
NASDAQCM
Biotechnology
United States
$1.09
▲
+0.01 (+0.93%)
CLOSED
—
OPEN
$1.07
HIGH
$1.10
LOW
$1.07
PREV CLOSE
$1.08
VOLUME
437.3K
0.34x avg
BID / ASK
0.78 / 1.36
spr 0.582
MARKET CAP
$84.8M
DAY RANGE
$1.07
$1.10
P/E (TTM)
—
Fwd -1.8
EPS (TTM)
-0.60
DIV YIELD
—
52W HIGH
$3.31
-67.1%
52W LOW
$0.7600
+43.4%
BETA
1.46
vs S&P 500
DES
FA
GP
OPT
HLDR
EARN
CMP
COMPARE
ASK DESK
AFTER-HOURS
$1.09
+0.00
(+0.00%)
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
CRDF
$1.09
▲
+0.93%
Chart
Valuation
Financials
Peers
News
CRDF · K 線技術分析（即時、可互動）
basic
pro
快速分析（約 90–120 秒）
K 線圖載入中…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，約 90–120 秒。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
One-Year Trajectory
RISK-OFF
251 BARS · -50.2% YOY
1-year price chart. Started at 2.17, currently 1.08, down 50.2 percent. Range 0.81 to 3.21 over 251 data points.
2025-09-05
$2.17 → $1.08 (-50.2%)
2026-09-03
§ Valuation
Loading § Valuation
§ Multi-Year Financials
Loading § Multi-Year Financials
§ Peers
Loading § Peers
§ Recent News
Loading § Recent News
EDITORIAL · NOT INVESTMENT ADVICE.
Data sources: Finnhub (quote / profile / news / peers) + Yahoo (stats) + SEC EDGAR XBRL (financials + DCF). All values cached for 5 minutes via ISR.
VALUATION
Deterministic Valuation (SEC EDGAR + Finnhub)
—
NO DCF
DCF Fair Value
—
DCF vs Spot
—
Comps Fair Value
$0.85
WACC Used
+7.0%
Terminal g
+3.5%
Verdict: strong-sell
· peers $0.85 (-21.8%)
Peers:
ACET
ALDX
OSTX
GOSS
KLRS
MAIA
MNOV
CTOR
⚠ DCF skipped: missing FCF or shares data from SEC EDGAR. Often the case for non-US issuers.
FINANCIALS
Multi-Year Financials (SEC XBRL)
RISK-OFF
YOY REV -13.2% · 3 FY
FY
Revenue
Net Income
OCF
FCF
Assets
2025-12
$593.0K
-$45.9M
-$37.9M
-$38.0M
$61.9M
2024-12
$683.0K
-$45.4M
-$37.7M
-$37.8M
$97.2M
2023-12
$488.0K
-$41.4M
-$30.9M
-$31.5M
$81.6M
PEERS
Sector & Industry Peers
CALM
10 PEERS · FINNHUB
ACET
ALDX
OSTX
GOSS
KLRS
MAIA
MNOV
CTOR
IBIO
SERA
NEWS
Recent News (past 14 days)
CALM
10 HEADLINES · LAST 14 DAYS
Cardiff Oncology to Participate in September 2026 Conferences
GlobeNewswire · 2026-09-02
CRDF: Second Quarter Earnings
Zacks Small Cap Research · 2026-08-17
William Blair Downgrades Cardiff Oncology to Market Perform From Outperform
MT Newswires · 2026-08-12
Cardiff Oncology: Q2 Earnings Snapshot
Associated Press · 2026-08-11
Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update
GlobeNewswire · 2026-08-11
Cardiff Oncology Insider Bought Shares Worth $1,000,000, According to a Recent SEC Filing
MT Newswires · 2026-07-16
Cardiff Oncology Announces $10 Million Registered Direct Offering to Strengthen Working Capital
InvestorsHub · 2026-07-15
Cardiff Oncology to Raise $10 Million in Share, Warrant Sale
MT Newswires · 2026-07-15